Mar 13, 2023 / 06:40PM GMT
François Brisebois - Oppenheimer & Co. Inc. - Moderator
Okay. Thanks for joining the Oppenheimer Healthcare Conference on a very busy time in the market. Appreciate you guys taking the time here. So our next presenting company is Dyne Therapeutics. We recently initiated coverage on the company with an outperform rating. Really interesting oligotherapeutic play for neuromuscular diseases, rare diseases that we'll go more into. But before that, just my side is Frank Brisebois. I'm one of the biotech analysts at the firm. And then who we have from Dyne joining in is, we have a Head of Corporate Communications Senior VP, Amy Reilly, and Chief Medical Officer, Wildon Farwell.
Questions and Answers:
François Brisebois - Oppenheimer & Co. Inc. - ModeratorThank you very much for joining. And with that, maybe if you could start with just an overview of Dyne and who you are and what you're working on.
Amy Reilly - Dyne Therapeutics Inc. - Head of Corporate Communications, Senior VP
Trustpilot
